investorscraft@gmail.com

AI Value of The Scotts Miracle-Gro Company (SMG) Stock

Previous Close$69.31
AI Value
Upside potential
Previous Close
$69.31
See other valuations:
Investing in stock

AI Investment Analysis of The Scotts Miracle-Gro Company (SMG) Stock

Strategic Position

The Scotts Miracle-Gro Company (SMG) is a leading manufacturer and marketer of branded consumer lawn and garden products, including fertilizers, grass seed, and pest control solutions. The company operates through three segments: U.S. Consumer, Hawthorne (a subsidiary focused on hydroponic and indoor gardening), and Other. SMG holds a dominant market position in North America, supported by well-known brands like Scotts, Miracle-Gro, and Ortho. Its competitive advantages include strong brand recognition, extensive distribution networks (e.g., Home Depot, Lowe’s), and innovation in organic and sustainable gardening solutions. The Hawthorne segment has grown significantly due to the expansion of the cannabis cultivation market, though it faces regulatory uncertainties.

Financial Strengths

  • Revenue Drivers: U.S. Consumer segment (~70% of FY2023 sales), Hawthorne (~25%), and Other (~5%). Key products include Miracle-Gro soil, fertilizers, and hydroponic equipment.
  • Profitability: Gross margin of ~30% in FY2023, with adjusted EBITDA of $575M. The company has faced recent profitability pressures due to Hawthorne’s underperformance and higher input costs. Net debt stood at ~$2.7B as of Q1 2024.
  • Partnerships: Collaborates with major retailers (e.g., Home Depot, Walmart) and has strategic ties to cannabis growers through Hawthorne.

Innovation

SMG invests in R&D for sustainable products, including water-efficient fertilizers and organic pest control. It holds numerous patents related to soil and plant nutrition technologies. Hawthorne drives innovation in hydroponic systems for cannabis cultivation.

Key Risks

  • Regulatory: Hawthorne’s growth is tied to cannabis legalization, which remains fragmented and subject to federal restrictions in the U.S. Potential EPA scrutiny over pesticide products.
  • Competitive: Competition from private-label brands and niche organic gardening companies. Hawthorne faces rivalry from hydroponic specialists like GrowGeneration.
  • Financial: High leverage (net debt/EBITDA ~4.7x in FY2023) and interest rate sensitivity. Hawthorne’s revenue declined 30% YoY in Q1 2024, raising concerns about segment stability.
  • Operational: Supply chain disruptions (e.g., peat moss shortages) and reliance on third-party manufacturing.

Future Outlook

  • Growth Strategies: Focus on core U.S. Consumer segment recovery, cost-cutting initiatives ($40M savings targeted in FY2024), and potential divestiture of non-core assets. Hawthorne aims to stabilize via operational efficiencies.
  • Catalysts: Q2 2024 earnings report (May 2024), potential federal cannabis reform, and seasonal demand uptick in spring/summer.
  • Long Term Opportunities: Macro trends favoring home gardening post-pandemic and cannabis legalization expansion (per BDSA forecasts).

Investment Verdict

SMG offers exposure to stable lawn/garden demand and high-growth cannabis ancillary markets, but near-term risks include leverage, Hawthorne’s volatility, and input cost inflation. A turnaround in Hawthorne and debt reduction could unlock value, but regulatory and competitive pressures warrant caution.

Data Sources

SMG FY2023 10-K, Q1 2024 earnings release, investor presentations, Bloomberg data.

Stock price and AI valuation

Historical valuation data is not available at this time.

HomeMenuAccount